Systematic (IUPAC) name | |
---|---|
(3aR,4R,4aS,8aR,9aS)- 4-{(E)-[(2R,6S)- 1,6-dimethylpiperidin- 2-yl]vinyl}- 3-methyldecahydronaphtho[2,3-c]furan- 1(3H)-one | |
Identifiers | |
CAS number | 6879-74-9 |
ATC code | None |
PubChem | CID 6436265 |
ChemSpider | 4940913 |
ChEMBL | CHEMBL277642 |
Chemical data | |
Formula | C22H35NO2 |
Mol. mass | 345.27 g/mol |
SMILES | eMolecules & PubChem |
InChI=1S/C22H35NO2/c1-14-7-6-9-17(23(14)3)11-12-19-18-10-5-4-8-16(18)13-20-21(19)15(2)25-22(20)24/h11-12,14-21H,4-10,13H2,1-3H3/b12-11+/t14-,15-,16+,17+,18-,19+,20-,21+/m0/s1
Key: FMPNFDSPHNUFOS-LPJDIUFZSA-N |
|
Therapeutic considerations | |
Pregnancy cat. | ? |
Legal status | ? |
(what is this?) (verify) |
Himbacine is an alkaloid isolated from the bark of Australian magnolias. Himbacine has been synthesized using a Diels-Alder reaction as a key step.[1] Himbacine's activity as a muscarinic receptor antagonist, with specificity for the Muscarinic acetylcholine receptor M2, made it a promising starting point in Alzheimer's disease research.[2][3] The development of a muscarinic antagonist based on Himbacine failed but an analog is now in clinical trials as a thrombin receptor antagonist.[4][5]
See also
References
- ^ Chackalamannil S, Davies RJ, Wang Y, et al. (March 1999). "Total Synthesis of (+)-Himbacine and (+)-Himbeline". J. Org. Chem. 64 (6): 1932–1940. doi:10.1021/jo981983. PMID 11674285.
- ^ Malaska MJ, Fauq AH, Kozikowski AP, Aagaard PJ, McKinney M (1995). "Chemical Modification of Ring C of Himbacine: Discovery of a Pharmacophoric Element for M2-Selectivity". Bioorganic and Medicinal Chemistry Letters 5 (1): 61–66. doi:10.1016/0960-894X(94)00459-S.
- ^ Chackalamannil S, Doller D, McQuade R, Ruperto V (2004). "Himbacine analogs as muscarinic receptor antagonists-effects of tether and heterocyclic variations". Bioorganic and Medicinal Chemistry Letters 14 (15): 3967–3970. doi:10.1016/j.bmcl.2004.05.047. PMID 15225708.
- ^ Chackalamannil S, Wang Y, Greenlee WJ, 'et al. (2008). "Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity". J. Med. Chem. 51 (11): 3061–3064. doi:10.1021/jm800180e. PMID 18447380.
- ^ "Blog entry about Himbacine and its history in drug development". http://pipeline.corante.com/archives/2008/05/13/in_which_i_hate_a_wonder_drug.php.